Clinical Trial

Starter Infant Formula With Synbiotics

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This randomized, double-blind, controlled intervention trial aims to evaluate the safety and efficacy of a starter infant formula supplemented with an HMO blend and a probiotic, and will provide evidence on the safety and efficacy of the innovative prebiotic/ probiotic blend to support age-appropriate infant growth, a healthy gut microbiome, gastrointestinal (GI) tolerance and GI health, and immune development.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-10-02; most recent amendment 2026-01-13.
Status change: Recruiting → Active, Not Recruiting 2024-06-04
Trial Details
NCT Number NCT06073652
Lead Sponsor Société des Produits Nestlé (SPN)
Collaborators: IQVIA Pty Ltd
Conditions Healthy Infants
Enrollment 240 participants
Start Date 2023-07-05
Primary Completion 2024-08-14 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-01-15